Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sam Amin

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Expert Review of Neurotherapeutics|July 31, 2024
An overview of ganaxolone as a treatment for seizures associated with cyclin-dependent kinase-like 5 deficiency disorderAlfie Gould, Sam Amin
British Journal of Clinical Pharmacology|October 6, 2018
The journey of metformin from glycaemic control to mTOR inhibition and the suppression of tumour growthSam Amin, Andrew Lux, Finbar O'Callaghan
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|September 24, 2019
Quality of life in patients with Tuberous Sclerosis Complex (TSC)Sam Amin, Andrew A Mallick, Andrew Lux, et al.
Frontiers in Medicine|September 15, 2022
Impact of facial angiofibromas in tuberous sclerosis complex and reported efficacy of available treatmentsMarie Monaghan, Pooja Takhar, Luke Langlands, et al.
Developmental Medicine and Child Neurology|October 7, 2023
Growth patterns in individuals with CDKL5 deficiency disorderKingsley Wong, George Davies, Helen Leonard, et al.
Archives of Disease in Childhood|February 11, 2026
Guidance for the referral of children and young people for consideration of neurosurgical interventions in the management of posture and tone (NIMPTs): a UK-wide consensus reportDaniel E Lumsden, Sam Amin, Sinead Barkey, et al.
Developmental Medicine and Child Neurology|December 10, 2016
Causes of mortality in individuals with tuberous sclerosis complexSam Amin, Andrew Lux, Nuala Calder, et al.
Pediatric Neurology|December 20, 2024
Measuring the Burden of Epilepsy Hospitalizations in CDKL5 Deficiency DisorderMohammed Junaid, Kingsley Wong, Minna A Korolainen, et al.
Frontiers in Neurology|November 11, 2021
Treatment Guidelines for Rare, Early-Onset, Treatment-Resistant Epileptic Conditions: A Literature Review on Dravet Syndrome, Lennox-Gastaut Syndrome and CDKL5 Deficiency DisorderRichard F Chin, Ana Mingorance, Benjamin Ruban-Fell, et al.
Eclinicalmedicine|March 8, 2021
The metformin in tuberous sclerosis (MiTS) study: A randomised double-blind placebo-controlled trialSam Amin, Andrew A Mallick, Hannah Edwards, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Expert Review of Neurotherapeutics|July 31, 2024
An overview of ganaxolone as a treatment for seizures associated with cyclin-dependent kinase-like 5 deficiency disorderAlfie Gould, Sam Amin
British Journal of Clinical Pharmacology|October 6, 2018
The journey of metformin from glycaemic control to mTOR inhibition and the suppression of tumour growthSam Amin, Andrew Lux, Finbar O'Callaghan
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|September 24, 2019
Quality of life in patients with Tuberous Sclerosis Complex (TSC)Sam Amin, Andrew A Mallick, Andrew Lux, et al.
Frontiers in Medicine|September 15, 2022
Impact of facial angiofibromas in tuberous sclerosis complex and reported efficacy of available treatmentsMarie Monaghan, Pooja Takhar, Luke Langlands, et al.
Developmental Medicine and Child Neurology|October 7, 2023
Growth patterns in individuals with CDKL5 deficiency disorderKingsley Wong, George Davies, Helen Leonard, et al.
Archives of Disease in Childhood|February 11, 2026
Guidance for the referral of children and young people for consideration of neurosurgical interventions in the management of posture and tone (NIMPTs): a UK-wide consensus reportDaniel E Lumsden, Sam Amin, Sinead Barkey, et al.
Developmental Medicine and Child Neurology|December 10, 2016
Causes of mortality in individuals with tuberous sclerosis complexSam Amin, Andrew Lux, Nuala Calder, et al.
Pediatric Neurology|December 20, 2024
Measuring the Burden of Epilepsy Hospitalizations in CDKL5 Deficiency DisorderMohammed Junaid, Kingsley Wong, Minna A Korolainen, et al.
Frontiers in Neurology|November 11, 2021
Treatment Guidelines for Rare, Early-Onset, Treatment-Resistant Epileptic Conditions: A Literature Review on Dravet Syndrome, Lennox-Gastaut Syndrome and CDKL5 Deficiency DisorderRichard F Chin, Ana Mingorance, Benjamin Ruban-Fell, et al.
Eclinicalmedicine|March 8, 2021
The metformin in tuberous sclerosis (MiTS) study: A randomised double-blind placebo-controlled trialSam Amin, Andrew A Mallick, Hannah Edwards, et al.
Pageof 3